The 20 Best Primary Mediastinal B-Cell Lymphoma (PMBCL) Doctors Near Me in Baltimore, MD

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine.

Christopher Melani is a primary care provider, practicing in Hematologist in Baltimore, Maryland. Dr. Melani is rated as a Distinguished provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Lymphomatoid Granulomatosis, Primary Mediastinal B-Cell Lymphoma (PMBCL), B-Cell Lymphoma, and Non-Hodgkin Lymphoma.

Jeffrey Galvin is a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Galvin is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Pneumomediastinum, and Interstitial Lung Disease.

Nancy Hardy is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Hardy is rated as an Advanced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Sanghoon Lee is a Holistic Medicine provider practicing medicine in Baltimore, Maryland. Mr. Lee is rated as an Advanced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL).

Susan Hodges is a Nurse Practitioner practicing medicine in Baltimore, Maryland. Ms. Hodges is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Smoldering Multiple Myeloma, Primary Mediastinal B-Cell Lymphoma (PMBCL), Classical Hodgkin Lymphoma, and Chronic Graft Versus Host Disease (cGvHD).

Aaron Rapoport is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Rapoport is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Teresa York is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. York is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Hereditary Spherocytosis, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.

Seung Lee is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Splenectomy.

Cecille Gumabon is a Physician Assistant practicing medicine in Baltimore, Maryland. She has been practicing medicine for over 10 years. Ms. Gumabon is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL).

Jean Yared is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Yared is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

David Riedel is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Riedel is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Febrile Neutropenia, Myelitis, and AIDS Dementia Complex.

Arpit Chhabra is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Chhabra is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Pineoblastoma, Nasopharyngeal Carcinoma, Medulloblastoma, and Olfactory Neuroblastoma.

Sandra Woodring is a Nurse Practitioner practicing medicine in Baltimore, Maryland. Ms. Woodring is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), ALK-Positive Non-Small Cell Lung Cancer, Relapsed Refractory Multiple Myeloma (RRMM), and Smoldering Multiple Myeloma. Ms. Woodring is currently accepting new patients.

Donald Slack is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Slack is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pneumonia, Interstitial Lung Disease, Acute Interstitial Pneumonia, Thyroidectomy, and Advanced Bronchoscopy.

Milos Miljkovic is a primary care provider, practicing in Hematologist in Baltimore, Maryland. Dr. Miljkovic is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Non-Hodgkin Lymphoma, Myasthenia Gravis, and Adult T-Cell Leukemia.

Mayer Gorbaty is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Gorbaty is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, and Multiple Myeloma.

Vishal Jindal is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Jindal is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His clinical expertise encompasses Childhood Iron Deficiency Anemia, Gaucher Disease Type 2, Gaucher Disease Type 1, and Gaucher Disease.